EPA:ALMDT - Euronext Paris - Matif - FR0011049824 - Common Stock - Currency: EUR
EPA:ALMDT (4/25/2025, 7:00:00 PM)
2.561
-0.03 (-1.12%)
The current stock price of ALMDT.PA is 2.561 EUR. In the past month the price increased by 3.27%. In the past year, price decreased by -14.63%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
VEE.DE | VEEVA SYSTEMS INC-CLASS A | 31.99 | 30.29B | ||
NXU.DE | NEXUS AG | 38.83 | 1.20B | ||
COP.DE | COMPUGROUP MEDICAL SE & CO K | 33.52 | 1.19B | ||
EQS.PA | EQUASENS | 13.29 | 560.53M | ||
CONTX.OL | CONTEXTVISION AB | 17.99 | 473.35M | ||
GPI.MI | GPI SPA | 2.47 | 256.72M | ||
CGM.PA | CEGEDIM SA | N/A | 169.20M | ||
AGFB.BR | AGFA-GEVAERT NV | N/A | 138.72M | ||
AJ91.DE | DOCCHECK AG | 20.63 | 50.19M | ||
M3V.DE | MEVIS MEDICAL SOLUTIONS AG | N/A | 47.68M | ||
ALINS.PA | INTRASENSE SAS | N/A | 15.05M |
MEDIAN Technologies SA engages in the development and market of software publishing solutions and provision of services in the field of medical imaging in oncology. The company is headquartered in Valbonne, Paca. The company went IPO on 2011-05-20. The firm develops lesion management solutions (LMS) to objectively measure and track cancerous or suspicious lesions, distribute a standardized oncologic report and centralize the lesion information for multidisciplinary review. The LMS line includes such products as LMS-Lung, a clinical application for the detection, evaluation and follow-up of lesions identified in CT images covering the chest; LMS-Track, a clinical application for the follow-up of oncology patients; and LMS-Liver, a clinical application for the initial evaluation and the follow-up of liver metastases and any other lesions identified in CT images covering the liver. The firm operates one subsidiary, Median Technologies Inc, based in the United States.
MEDIAN TECHNOLOGIES
Les Deux Arcs - Batiment B 1800, Route des Cretes
Valbonne PACA FR
Employees: 256
Company Website: https://mediantechnologies.com/
Investor Relations: http://mediantechnologies.com/investors/
Phone: 33493333777
The current stock price of ALMDT.PA is 2.561 EUR. The price decreased by -1.12% in the last trading session.
The exchange symbol of MEDIAN TECHNOLOGIES is ALMDT and it is listed on the Euronext Paris - Matif exchange.
ALMDT.PA stock is listed on the Euronext Paris - Matif exchange.
11 analysts have analysed ALMDT.PA and the average price target is 16.9 EUR. This implies a price increase of 559.82% is expected in the next year compared to the current price of 2.561. Check the MEDIAN TECHNOLOGIES stock analysts ratings, price target forecast and up-and down grades for more detailed information.
MEDIAN TECHNOLOGIES (ALMDT.PA) has a market capitalization of 48.66M EUR. This makes ALMDT.PA a Nano Cap stock.
MEDIAN TECHNOLOGIES (ALMDT.PA) currently has 256 employees.
MEDIAN TECHNOLOGIES (ALMDT.PA) has a support level at 2.48 and a resistance level at 2.57. Check the full technical report for a detailed analysis of ALMDT.PA support and resistance levels.
The Revenue of MEDIAN TECHNOLOGIES (ALMDT.PA) is expected to decline by -11.35% in the next year. Check the estimates tab for more information on the ALMDT.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ALMDT.PA does not pay a dividend.
MEDIAN TECHNOLOGIES (ALMDT.PA) will report earnings on 2025-04-29, after the market close.
MEDIAN TECHNOLOGIES (ALMDT.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.29).
ChartMill assigns a technical rating of 2 / 10 to ALMDT.PA. When comparing the yearly performance of all stocks, ALMDT.PA is a bad performer in the overall market: 91.48% of all stocks are doing better.
ChartMill assigns a fundamental rating of 1 / 10 to ALMDT.PA. Both the profitability and financial health of ALMDT.PA have multiple concerns.
Over the last trailing twelve months ALMDT.PA reported a non-GAAP Earnings per Share(EPS) of -1.29. The EPS increased by 3.86% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -77.03% | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 85% to ALMDT.PA. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of 6.45% and a revenue growth -11.35% for ALMDT.PA